MILPITAS, CA. September 7, 2018 – MagArray, the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced the prestigious selection of our late-breaking abstract for oral presentation at the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer.

After a rigorous peer review process, “Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Test” will be presented by Anil Vachani, MD, Associate Professor of Medicine within the Pulmonary, Allergy, and Critical Care Division of the University of Pennsylvania. Our cutting-edge research will be discussed on Wednesday, September 26, 2018 during the Early Stage Lung Cancer: Present and Future Session from 10:30-noon. This important assembly will be moderated by Drs. Aman S. Coonar (Thoracic Surgeon at Cambridge University in the UK) and Roy H. Decker, (Professor of Therapeutic Radiology at Yale Cancer Center).

“It is a tremendous honor that our research on a novel, proteomic assay for lung nodule characterization has been selected by the esteemed reviewers at the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer”, said Luis Carbonell, CEO of MagArray. “Predicting the risk of developing lung cancer is a difficult task. Overdiagnosis is a serious problem in screening detected lung cancers. Plasma protein biomarkers, such as the assay described herein, may be particularly important in helping to select those patients appropriate for serial surveillance by further enhancing the quantitative, noninvasive assessment of these nodules.”

The MagArray CLIA-certified laboratory is prepared to process orders of the REVEAL test from clinicians and reference laboratories. Clinicians and patients interested in gaining access to REVEAL should call 619.738.3251, email or request information from the company’s website at

About MagArray, Inc.: Founded by a team of professors from Stanford University and located in Milpitas, CA, MagArray has developed a simple, ultra-sensitive, and multiplex system for developing and processing medical diagnostics. Derived from magnetic technologies used in the computer disk drive industry, the MagArray system features many unique advantages over the current industry-leading technologies. MagArray has received past support from the National Cancer Institute’s SBIR program as well as from private investors.

About the WCLC: The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, attracting over 7,000 researchers, physicians

and specialists from more than 100 countries. The conference will cover a wide range of disciplines and unveil research studies and clinical trial results. For more information, visit Follow the conference on social media with: #WCLC2018.

About the IASLC: The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit for more information. You can also follow the IASLC on Twitter, Facebook, LinkedIn and Instagram.